40 related articles for article (PubMed ID: 8161744)
1. [The value of the liver-specific superparamagnetic contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors versus metastases].
Vogl TJ; Hammerstingl R; Pegios W; Hamm B; Eibl-Eibesfeldt A; Woessmer B; Lissner J; Felix R
Rofo; 1994 Apr; 160(4):319-28. PubMed ID: 8161744
[TBL] [Abstract][Full Text] [Related]
2. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
3. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
[TBL] [Abstract][Full Text] [Related]
4. [Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases].
Ham B; Reichel M; Vogl T; Taupitz M; Wolf KJ
Rofo; 1994 Jan; 160(1):52-8. PubMed ID: 8305693
[TBL] [Abstract][Full Text] [Related]
5. Detection of focal hepatic lesions: effects of superparamagnetic iron oxide (AMI-25) on magnetic resonance imaging of the liver using T2-weighted fast spin-echo sequences and gradient-and-spin-echo sequences at 1.0 tesla.
Jung G; Krahe T; Kugel H; Gieseke J; Walter C; Lackner K
Invest Radiol; 1998 Feb; 33(2):61-7. PubMed ID: 9493719
[TBL] [Abstract][Full Text] [Related]
6. [The MR tomography of focal liver lesions with the superparamagnetic contrast agent AMI-25 at 1.5 tesla].
Duda SH; Laniado M; Kopp AF; Grönewäller E; Aicher KP; Pavone P; Jehle E; Claussen CD
Rofo; 1994 Jan; 160(1):46-51. PubMed ID: 8305692
[TBL] [Abstract][Full Text] [Related]
7. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
8. [New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors].
Daldrup HE; Reimer P; Rummeny EJ; Tombach B; Berns T; Balzer T; Schimpfky C; Peters PE
Radiologe; 1995 Aug; 35(8):486-93. PubMed ID: 7568792
[TBL] [Abstract][Full Text] [Related]
9. [Superparamagnetic iron oxide in the differential diagnosis of focal hepatic lesions using a 0.5-tesla magnetic resonance apparatus].
Di Cesare E; Cariello G; Marchese F; Michelini O; Costanzi A; Catalucci A; Splendiani A; Masciocchi C
Radiol Med; 1998 Jun; 95(6):593-8. PubMed ID: 9717541
[TBL] [Abstract][Full Text] [Related]
10. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
[TBL] [Abstract][Full Text] [Related]
12. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences.
Schwartz LH; Seltzer SE; Adams DF; Tempany CM; Piwnica-Worms DR; Silverman SG; Herman L; Herman LT; Hooshmand R
Invest Radiol; 1994 Jun; 29 Suppl 2():S21-3. PubMed ID: 7928234
[No Abstract] [Full Text] [Related]
13. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging.
Bellin MF; Zaim S; Auberton E; Sarfati G; Duron JJ; Khayat D; Grellet J
Radiology; 1994 Dec; 193(3):657-63. PubMed ID: 7972804
[TBL] [Abstract][Full Text] [Related]
14. [Clinical application of AMI-25 (superparamagnetic iron oxide) for the MR imaging of hepatic tumors: a multicenter clinical phase III study].
Yoshikawa K; Sasaki Y; Ogawa N; Sakuma S
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Feb; 54(2):137-53. PubMed ID: 8121779
[TBL] [Abstract][Full Text] [Related]
15. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
16. Clinical results with Resovist: a phase 2 clinical trial.
Reimer P; Rummeny EJ; Daldrup HE; Balzer T; Tombach B; Berns T; Peters PE
Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
[TBL] [Abstract][Full Text] [Related]
17. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
[TBL] [Abstract][Full Text] [Related]
18. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration.
Grandin C; Van Beers BE; Robert A; Gigot JF; Geubel A; Pringot J
J Comput Assist Tomogr; 1995; 19(3):412-8. PubMed ID: 7790551
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic iron oxide-enhanced magnetic resonance imaging of experimental liver tumors after mitomycin C administration.
Clement O; Frija G; Chambon C; Schouman-Clayes E
Invest Radiol; 1992 Mar; 27(3):230-5. PubMed ID: 1551774
[TBL] [Abstract][Full Text] [Related]
20. Experience with Resovist in gastroenterologic radiology and intervention.
Vogl TJ; Schwarz W; Marquart F; Parmentier S; Götz B; Thalhammer A; Hammerstingl R
Eur Radiol; 2004 Jan; 14 Suppl 1():C7-9. PubMed ID: 15113060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
